Literature DB >> 3481314

Chemotherapy of otitis media with ofloxacin.

T Lenarz1.   

Abstract

This study evaluated the therapeutic role of ofloxacin in different forms of otitis media. After identifying the infecting bacteria in 250 patients with acute otitis media, or chronic otitis media, the clinical efficacy of orally administered ofloxacin 200mg twice daily was assessed in 45 patients from each of these groups. The clinical results were comparable with those obtained after conventional local and oral antibiotic therapy. Microbiological examination of the ear secretions revealed Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae and Haemophilus influenzae to be the main pathogens in acute otitis media, whereas in chronic otitis media P. aeruginosa and Proteus sp. were detected in most of the cases. Ofloxacin concentrations in secretions and mucosa specimens of the middle ear exceeded serum concentrations by more than 2-fold. On the basis of these preliminary results, ofloxacin appears to be an effective orally administered agent, without ototoxicity, which is effective against S. aureus and P. aeruginosa, 2 important pathogens in middle ear infections. Ofloxacin should be considered as an alternative for the therapy of otitis media, especially the chronic forms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3481314     DOI: 10.2165/00003495-198700341-00030

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  [Tissue concentration and effectiveness of ofloxacin in surgical patients].

Authors:  W Düben; A Student; M Jablonski; R Malottke
Journal:  Infection       Date:  1986       Impact factor: 3.553

2.  Mutational resistance to 4-quinolone antibacterial agents.

Authors:  J T Smith
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

3.  Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.

Authors:  M Verho; V Malerczyk; E Dagrosa; A Korn
Journal:  Pharmatherapeutica       Date:  1985

4.  [New oral quinolone compounds in chronic bronchitis].

Authors:  B I Davies; F P Maesen; J P Teengs; C Baur
Journal:  Infection       Date:  1986       Impact factor: 3.553

5.  Ofloxacin in oral chemotherapy of acute and chronic otitis media.

Authors:  T Lenarz
Journal:  Infection       Date:  1986       Impact factor: 3.553

6.  [Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences].

Authors:  T Lenarz
Journal:  Infection       Date:  1986       Impact factor: 3.553

  6 in total
  5 in total

1.  Protective effects of local administration of ciprofloxacin on the risk of pneumococcal meningitis after cochlear implantation.

Authors:  Benjamin P C Wei; Roy M Robins-Browne; Robert K Shepherd; Kristy Azzopardi; Graeme M Clark; Stephen J O'Leary
Journal:  Laryngoscope       Date:  2006-12       Impact factor: 3.325

2.  Granulation tissue concentrations of ofloxacin after oral administration in invasive external otitis.

Authors:  M Z Himmelfarb; D Zikk; Y Rapoport; C Redianu; I Shalit
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

3.  Concentrations of ofloxacin in ear and nasal tissues.

Authors:  P Tolsdorff
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  Clinical experiences with ofloxacin sequential therapy in chronic ear infections.

Authors:  W Heppt; H Lutz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

5.  Tissue and serum concentrations of ofloxacin in the ear region following a single daily oral dose of 400 mg.

Authors:  P Tolsdorff
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.